Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1

Conditions

Pain, Postoperative 19Breast Neoplasms 13Brain Neoplasms 11Agnosia 7Neoplasms 6Lung Neoplasms 5Delirium 5Thyroid Neoplasms 4Stomach Neoplasms 4Pituitary Neoplasms 3Pain 3Inflammation 3Emergence Delirium 3Colorectal Neoplasms 3Chronic Pain 3Urinary Bladder Neoplasms 2Supratentorial Neoplasms 2Rectal Neoplasms 2Prostatic Neoplasms 2Pheochromocytoma 2Pain, Intractable 2Neoplasm Metastasis 2Liver Neoplasms 2Dexmedetomidine 2Colonic Neoplasms 2Central Nervous System Diseases 2Abdominal Neoplasms 2Thrombosis 1Spinal Cord Neoplasms 1Sleep Initiation and Maintenance Disorders 1

Interventions

resiniferatoxin 3Ketamine 3Morphine 2Methadone 2Dexmedetomidine 2ziconotide 1substance P-saporin 1Standard of Care 1Sodium Chloride 1Ropivacaine 1Registries 1Pregabalin 1Passive Cutaneous Anaphylaxis 1Midazolam 1Lidocaine 1Infusion Pumps, Implantable 1Hydromorphone 1Fentanyl 1Calcium Dobesilate 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Pain, Intractable × Dexmedetomidine × Clear all
NCT03936205 2019-05-14

Dexmedetomidine Addition to Morphine in Patients With Metastatic Cancer

Hotel Dieu de France Hospital

Phase 2/3 Completed
18 enrolled

Neoplasm Metastasis, Pain, Intractable

NCT01687751 2015-05-25

Pilot Study Comparing Treatment With Dexmedetomidine to Midazolam for Symptom Control in Advanced Cancer Patients

Fraser Health

Phase 2 Withdrawn
Other

Death, Delirium, Dyspnea, Nausea, Neoplasms, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡